Triple Intralesional Therapy with Triamcinolone, 5-Fluorouracil, and Hyaluronidase in the Management of Keloids: A Synergistic Approach with Favorable Clinical Outcomes.
International Journal of Drug Delivery Technology · 02.06.2026 · 16 (44s)
DOI: 10.25258/ijddt.16.44s.110 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Drug Delivery Technology, online erschienen am 02.06.2026. Verfasst von Mahima SS und 1 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Keloids are benign fibroproliferative disorders characterized by excessive collagen deposition and high recurrence rates following conventional therapies. Monotherapy often yields suboptimal outcomes, prompting the exploration of combination regimens targeting multiple pathogenic pathways.
Aim
To evaluate the clinical efficacy and safety of triple intralesional therapy with triamcinolone acetonide, 5-fluorouracil, and hyaluronidase in the management of keloids. Case Description: A 50-year-old male presented with a long-standing presternal keloid measuring 6 × 4 cm, associated with pruritus and cosmetic concern. The lesion developed following acne and had not received prior treatment. The patient was treated with intralesional injections of triamcinolone acetonide (10 mg/mL), 5-fluorouracil (50 mg/mL), and hyaluronidase (1500 IU) administered at three-week intervals using a multiple puncture technique. A total of five sessions were completed.
Results
Progressive clinical improvement was observed with each session. By the end of treatment, there was significant reduction in scar thickness, improved pliability, and complete resolution of pruritus. No major adverse effects such as ulceration, infection, or pigmentary changes were noted. At six-month follow-up, there was no evidence of recurrence, and patient satisfaction was high.
Conclusion
Triple intralesional therapy demonstrates a synergistic effect by targeting inflammation, fibroblast proliferation, and extracellular matrix remodeling. It appears to be a safe, effective, and minimally invasive treatment modality for keloids, with favorable clinical outcomes and low recurrence rates. This approach may serve as a promising alternative to conventional monotherapies, particularly in resource-limited settings.
Zitieren
APA
SS, M., & Kandaswamy, K. (2026). Triple Intralesional Therapy with Triamcinolone, 5-Fluorouracil, and Hyaluronidase in the Management of Keloids: A Synergistic Approach with Favorable Clinical Outcomes. International Journal of Drug Delivery Technology, 16(44s). https://doi.org/10.25258/ijddt.16.44s.110
Vancouver
SS M, Kandaswamy K. Triple Intralesional Therapy with Triamcinolone, 5-Fluorouracil, and Hyaluronidase in the Management of Keloids: A Synergistic Approach with Favorable Clinical Outcomes. International Journal of Drug Delivery Technology. 2026;16(44s). doi:10.25258/ijddt.16.44s.110
BibTeX
@article{SS2026,
author = {SS, Mahima and Kandaswamy, Kandaswamy},
title = {Triple Intralesional Therapy with Triamcinolone, 5-Fluorouracil, and Hyaluronidase in the Management of Keloids: A Synergistic Approach with Favorable Clinical Outcomes},
journal = {International Journal of Drug Delivery Technology},
year = {2026},
volume = {16},
number = {44s},
doi = {10.25258/ijddt.16.44s.110}
}
EUVIMED